Skip to main content

ADVERTISEMENT

Stents

Case Series
07/12/2023

Sitaram Barath, MD, FNVIR1; Virendra Meena, MD1; Shikhar Singh, MD2

1Department of Radiodiagnosis, Geetanjali Medical College and Hospital, Udaipur, Rajasthan, India; 2Aarthi Scans & Labs, Delhi, India

Sitaram Barath, MD, FNVIR1; Virendra ...
In this case series, the authors describe the technical nuances of successful revascularization in chronic mesenteric ischemia caused by stenosis, occlusion, or dissection of the superior mesenteric artery.
In this case series, the authors describe the technical nuances of successful revascularization in chronic mesenteric ischemia caused by stenosis, occlusion, or dissection of the superior mesenteric artery.
In this case series, the authors...
07/12/2023
Vascular Disease Management
Clinical and Industry News
03/06/2019
BIO-RESORT RCT Three-Year Data Analysis Shows a Consistent Trend Towards Lower Target Vessel Failure Rates for Orsiro Compared to Resolute Integrity and Synergy Washington, D.C. and BUELACH, Switzerland, March 6, 2019 – Three-year outcome...
BIO-RESORT RCT Three-Year Data Analysis Shows a Consistent Trend Towards Lower Target Vessel Failure Rates for Orsiro Compared to Resolute Integrity and Synergy Washington, D.C. and BUELACH, Switzerland, March 6, 2019 – Three-year outcome...
BIO-RESORT RCT Three-Year Data...
03/06/2019
Cath Lab Digest
Case Report
11/27/2018

Kyle Macdonald, BS, Kirk Minkus, MD, Charles Jost, MD, MS, 

Mountain Vista Medical Center, Mesa, Arizona

Kyle Macdonald, BS, Kirk Minkus, MD, ...
Here, we will discuss the use of excimer laser coronary atherectomy (ELCA) for an uncrossable obstruction due to stent fracture and in-stent restenosis (ISR).
Here, we will discuss the use of excimer laser coronary atherectomy (ELCA) for an uncrossable obstruction due to stent fracture and in-stent restenosis (ISR).
Here, we will discuss the use of...
11/27/2018
Cath Lab Digest
Case Report
06/06/2016

David W. Drucker, MD, FACC, FSCAI, Langhorne, Pennsylvania

David W. Drucker, MD, FACC, FSCAI, La...
Here, we discuss our experience with the NIRxcell stent in two challenging cases, a male with an acute coronary syndrome (ACS) and multiple comorbidities, and a female with complicated coronary anatomy and a history of medical...
Here, we discuss our experience with the NIRxcell stent in two challenging cases, a male with an acute coronary syndrome (ACS) and multiple comorbidities, and a female with complicated coronary anatomy and a history of medical...
Here, we discuss our experience...
06/06/2016
Cath Lab Digest
News
05/09/2016
News: Michigan Outpatient Vascular Institute, (Dearborn Michigan) recently became the first center in the state of Michigan to enroll subjects in the clinical trial (MIMICS-2) of an investigational nitinol stent for femoropopliteal artery...
News: Michigan Outpatient Vascular Institute, (Dearborn Michigan) recently became the first center in the state of Michigan to enroll subjects in the clinical trial (MIMICS-2) of an investigational nitinol stent for femoropopliteal artery...
News: Michigan Outpatient...
05/09/2016
Cath Lab Digest
08/01/2015

A conversation with Dr. Marty Leon and Dr. Kobi Richter. 

Dr. Marty Leon is Professor of Medicine, Columbia University, Director, Center for Interventional Vascular Therapy and Cardiac Catheterization Laboratories – NY Presbyterian Hospital/Columbia; Founder, Cardiovascular Research Foundation and Transcatheter Cardiovascular Therapeutics (TCT) conference. Kobi Richter, PhD,  is one of the founders of Medinol, a medical device company based in Israel. Dr. Richter is Chairman of the Board and Chief Technology Officer for Medinol.

A conversation with Dr. Marty Leon an...
Medinol introduced the NIR stent in Europe in 1996 and in the United States in 1998, and captured the leading market share in both markets. We have continued to develop new generations of stents with the NIR Elite, NIROYAL, NIRflex and...
Medinol introduced the NIR stent in Europe in 1996 and in the United States in 1998, and captured the leading market share in both markets. We have continued to develop new generations of stents with the NIR Elite, NIROYAL, NIRflex and...
Medinol introduced the NIR stent...
08/01/2015
Cath Lab Digest
Your Path to Success: Expert Advice
08/01/2015

Marsha Knapik, RN, MSN, Director, Corazon Inc., Pittsburgh, Pennsylvania

Marsha Knapik, RN, MSN, Director, Cor...
The real challenge is how to adapt these new technologies into day-to-day work while watching the horizon to see which new technology will emerge as the next great “disrupter” in cardiovascular care.  
The real challenge is how to adapt these new technologies into day-to-day work while watching the horizon to see which new technology will emerge as the next great “disrupter” in cardiovascular care.  
The real challenge is how to...
08/01/2015
Cath Lab Digest
Clinical Editor's Corner
10/15/2014
Morton Kern, MD
Morton Kern, MD
“I just put two drug-eluting stents into a native vessel and a distal graft anastomosis in a patient who is already on clopidogrel AND who has an aspirin allergy that cannot be touched or addressed. What additional drug, if any, would you...
“I just put two drug-eluting stents into a native vessel and a distal graft anastomosis in a patient who is already on clopidogrel AND who has an aspirin allergy that cannot be touched or addressed. What additional drug, if any, would you...
“I just put two drug-eluting...
10/15/2014
Cath Lab Digest
08/06/2014
George Kassimis, MD, MSc, PhD; Niket Patel, MBBS, BSc(Hons), MRCP; Adrian P. Banning, MBBS, MD
George Kassimis, MD, MSc, PhD; Niket...
The OPN NC balloon appears to offer a new means of dilating underexpanded stents when other NC balloons have failed.
The OPN NC balloon appears to offer a new means of dilating underexpanded stents when other NC balloons have failed.
The OPN NC balloon appears to...
08/06/2014
Cath Lab Digest